PatientsInvestors

Clinical Study Index

Outset Dialysis Research and Papers

Filter studies:

Study Name
Date Published
Source
Primary Author
Setting
Subject
Addressing the Quality of Dialysis Care Through an Insourced Model
2025-04
NKF 2025
McGill
Acute
Hospital insourcing
Improvement in Depressive Symptoms and Quality-of-Life in HHD Patients
2024-10
ASN 2024
Silva
Home
Patient experience
Caregiver Support on Tablo Home Hemodialysis
2024-10
ASN 2024
Silva
Home
Clinical outcomes, Other, Patient experience, Resource utilization, Safety and efficacy, Antibiotic dosing, Hospital insourcing, Health economics, Human factors
Intensive care unit improves dialysis care quality while reducing costs
2024-07
Journal of Medical Economics
Greenleaf Nichols
clinical_evidence_ta_subject_2, clinical_evidence_ta_subject_7
Patterns in Saline Flush Intervals Observed in Home Hemodialysis (HHD): The Scheduling of Saline Flushes and its Correlation with HD Treatment Variables
2024-04
NKF 2024
Thiruvenkadam
clinical_evidence_ta_subject_2, clinical_evidence_ta_subject_1
Antibiotic dosing recommendations in critically ill patients receiving new innovative kidney replacement therapy
2024-02
BMC Nephrology
Lewis
clinical_evidence_ta_subject_2, clinical_evidence_ta_subject_1, clinical_evidence_ta_subject_6
Rural Alaskan Experience Insourcing Innovative Dialysis Technology
2023-11
ASN 2023
Russell
clinical_evidence_ta_subject_2
Utilization of Extended Training Decay Periods to Evaluate Training Effectiveness in Home Dialysis Devices
2023-11
ASN 2023
Lim
clinical_evidence_ta_subject_1, clinical_evidence_ta_subject_5, clinical_evidence_ta_subject_9
Patient Reported Outcomes (PRO) Among Patients Receiving Home Hemodialysis (HHD) with the Tablo® Hemodialysis System
2023-11
ASN 2023
Wazny
clinical_evidence_ta_subject_2, clinical_evidence_ta_subject_1
Characteristics of Tablo Home Hemodialysis Users in Medicare Fee-for-Service
2023-11
ASN 2023
Dunning
clinical_evidence_ta_subject_8
Characteristics of the First 500 Tablo Home Hemodialysis Users
2023-11
ASN 2023
Dunning
clinical_evidence_ta_subject_8
Experience of Starting a Rural Home Hemodialysis Program
2023-04
AJKD/NKF SCM
Story
clinical_evidence_ta_subject_2, clinical_evidence_ta_subject_1
Redefining dialysis care on the Hawaiian Islands: reducing health disparities and resource utilization
2023-04
AJKD; NKF 2023
Silva
clinical_evidence_ta_subject_1, clinical_evidence_ta_subject_3
The Transition from PD to Home Hemodialysis At Hospital Discharge
2023-04
AJKD; NKF SCM
Khan
clinical_evidence_ta_subject_2, clinical_evidence_ta_subject_1
Gender Biases in Nephrology: a 2022 Survey of Female Nephrologists
2023-04
AJKD; NKF 2023
Silva
clinical_evidence_ta_subject_4
Providers Can Leverage Home Hemodialysis to Reduce Total Cost of Care in Risk-based Contracts with Medicare Advantage Organizations
2023-04
AJKD; NKF 2023
Dunning
clinical_evidence_ta_subject_2, clinical_evidence_ta_subject_3, clinical_evidence_ta_subject_8
Home Hemodialysis can help Reduce Total Cost of Care among Medicare Advantage Members with ESRD
2023-04
AJKD; NKF 2023
Dunning
clinical_evidence_ta_subject_2, clinical_evidence_ta_subject_3
Building Trust in Your Critical Care Home Device
2023-03
HFES 2023
Lim
clinical_evidence_ta_subject_5
Performing Comparative UI and Use-Related Risk Analyses to Justify CDRH-regulated Devices’ Safety and Effectiveness in Lieu of HF Validation
2023-03
HFES 2023
Strochlic
clinical_evidence_ta_subject_5, clinical_evidence_ta_subject_9
Early Patient Experience with the Tablo Hemodialysis System
2016-11
JASN
Alvarez
clinical_evidence_ta_subject_1
Clinical Experience with a New Hemodialysis System Designed for In-Center Self-Care Hemodialysis
2017
SelfCare Journal
Alvarez
clinical_evidence_ta_subject_1
Real World In-Center Urea Clearance Experience with a Novel Hemodialysis System
2018-01
Hemodial. Int.
Alvarez
clinical_evidence_ta_subject_2
In-Vivo Dialysis Kinetics of 300 mL/min and 500 mL/min Dialysate Flows
2018-10
JASN
Augustin
clinical_evidence_ta_subject_2
Urea Clearance Results in Patients Dialyzed Thrice Weekly Using a Dialysate Flow of 300 mL/min.
2019-02
Hemodial. Int.
Alvarez
clinical_evidence_ta_subject_2
A Single Center Experience Piloting the Tablo Hemodialysis System for Intermittent (IHD) in an Acute Hospital Setting – a Quality Improvement Project
2019-10
JASN
Sylvia-Reardon
clinical_evidence_ta_subject_2
Ten thousand consecutive treatments using the Tablo Hemodialysis system in hospitals and clinics
2019-10
JASN
Aragon
clinical_evidence_ta_subject_3
Safety and Efficacy of the Tablo Hemodialysis System for in‐Center and Home Hemodialysis
2019-11
Hemodial Int
Plumb
clinical_evidence_ta_subject_5
Evaluation of Clinical Lab Data from the Tablo Hemodialysis Home IDE Trial
2020-01
Hemodial Int
Lim
clinical_evidence_ta_subject_2
Improved Quality of Sleep on Four Day per Week Home Hemodialysis with Tablo
2020-01
Hemodial Int
Aragon
clinical_evidence_ta_subject_1
High Treatment Adherence and Ultrafiltration Rates on Four Day per Week Home Hemodialysis with Tablo
2020-01
Hemodial Int
Aragon
clinical_evidence_ta_subject_2
Single Center Case Study on Acute Dialysis with a Dialysate Flow Rate of 300 mL/min compared to ≥ 500 mL/min
2020-02
CRRT Online
Aragon
clinical_evidence_ta_subject_2
Patient Device Preference for Home Hemodialysis: A Subset Analysis of the Tablo Home IDE Trial Subset Analysis of the Tablo Home IDE Trial
2020-04
AJKD
Chahal
clinical_evidence_ta_subject_1
Patient-reported outcomes from the investigational device exemption study of the Tablo hemodialysis system
2020-08
Hemodial Int
Chertow
clinical_evidence_ta_subject_1
Urgent Training with the Tablo Hemodialysis System in Response to COVID-19
2020-10
JASN
Aragon
clinical_evidence_ta_subject_1
Self‐care training using the Tablo hemodialysis system
2020-10
Hemodial Int
Plumb
clinical_evidence_ta_subject_1
Transition of a Home Hemodialysis Program to the Tablo System
2021-03
ADC 2021
Henner
clinical_evidence_ta_subject_2
Improved Dialysis Symptom Index with Tablo Thrice Weekly Dialysis
2021-04
NKF SCM
Aragon
clinical_evidence_ta_subject_1
An Academic Hospital’s In-patient Dialysis unit’s staff and patient experience with use of Tablo Hemodialysis System
2021-04
NKF SCM
DeSilva
clinical_evidence_ta_subject_7
Home Hemodialysis with the Tablo System: The First 1000 Real-World Treatments
2021-11
JASN
Aragon
clinical_evidence_ta_subject_2
Hidden Costs of Conversion from Peritoneal Dialysis to Hemodialysis
2022-04
ASN KW
Weinhandl
clinical_evidence_ta_subject_2, clinical_evidence_ta_subject_8
Tablo Hemodialysis System Increases Patient Likelihood for HHD Adoption
2022-04
ASN KW
Saffer
clinical_evidence_ta_subject_1
Comparison of Mid and Conventional Dialysate Flow in Critically Ill Patients Undergoing Intermittent Dialysis
2022-11
ASN KW
Demirjian
clinical_evidence_ta_subject_2
Human Factors Validation of the Tablo Hemodialysis System with Health Care Practitioners
2022-11
ASN KW
Lim
clinical_evidence_ta_subject_1, clinical_evidence_ta_subject_9
Clinician and Patient Support through Supply Chain Innovation during the COVID-19 Pandemic
2022-11
ASN KW
Khangura
clinical_evidence_ta_subject_3
Initial Experience with Home Hemodialysis Using the Tablo Hemodialysis System
2022-11
ASN KW
Weinhandl
clinical_evidence_ta_subject_2
The Tablo Hemodialysis System at Home: Comparing Real World to the IDE Trial
2022-11
ASN KW
Schumacher
clinical_evidence_ta_subject_2
A Simulation of Strategies to Launch a Home Therapies Program in a Conventional Hemodialysis Facility
2022-11
ASN KW
Weinhandl
clinical_evidence_ta_subject_1
Human Factors Validation of the Tablo Hemodialysis System in Home Patients
2022-11
ASN KW
Lim
clinical_evidence_ta_subject_1